Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 0615-8113

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 0615-8113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Pantoprazole Sodium Dr Tabs 20mg Aurobindo 1)

Chemical structure diagram of Pantoprazole Sodium, showing its molecular components including a sulfoxide group, benzene rings with methoxy and difluoromethoxy substitutions, a sodium ion, and 1.5 molecules of water associated in the structure.*

FDA Label Image

Principal Display Panel-pantoprazole Sodium Dr Tab 20mg Bingo Label (Pantoprazole Sodium Dr Tabs 20mg Aurobindo 2)

Pantoprazole Sodium 20 mg delayed-release tablets label sheet featuring multiple individual labels. Each label displays the drug name, strength, dosage form, NDC 65862-559-90, lot number 8113, and expiration date fields. Packaging and labeling by Vangard Labs, Glasgow, KY. Instructions include store at 20°-25°C and do not split, chew, or crush tablets. For institutional use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.